Viking Therapeutics | 8-K: Current report
Viking Therapeutics | 8-K: Viking Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Viking Therapeutics | 8-K: Viking Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Viking Therapeutics | 8-K: Current report
Viking Therapeutics | 8-K: Current report
Viking Therapeutics | S-8 POS: S-8 POS
Viking Therapeutics | S-8 POS: S-8 POS
Viking Therapeutics | S-8 POS: S-8 POS
Viking Therapeutics | S-8 POS: S-8 POS
Viking Therapeutics | S-8 POS: S-8 POS
Viking Therapeutics | S-8 POS: S-8 POS
Viking Therapeutics | S-8 POS: S-8 POS
Viking Therapeutics | S-8 POS: S-8 POS
Viking Therapeutics | S-8 POS: S-8 POS
Viking Therapeutics | S-8 POS: S-8 POS
Viking Therapeutics | S-8 POS: S-8 POS
Viking Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Viking Therapeutics | 8-K: Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Viking Therapeutics | DEFA14A: Others
Viking Therapeutics | DEF 14A: Definitive information statements
No Data
No Data